Making the change to area under the curve-based vancomycin dosing

被引：63

作者：

Heil, Emily L. ^{[1
,2
]}

Claeys, Kimberly C. ^{[1
,2
]}

Mynatt, Ryan P. ^{[3
]}

Hopkins, Teri L. ^{[4
]}

Brade, Karrine ^{[5
]}

Watt, Ian ^{[2
]}

Rybak, Michael J. ^{[3
,6
]}

Pogue, Jason M. ^{[7
]}

机构：

[1] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA

[2] Univ Maryland, Med Ctr, Dept Pharm, Baltimore, MD 21201 USA

[3] Detroit Receiving Hosp & Univ Hlth Ctr, Detroit Med Ctr, Dept Pharm, Detroit, MI USA

[4] South Texas Vet Hlth Care Syst, Dept Pharm, San Antonio, TX USA

[5] Boston Med Ctr, Dept Pharm, Boston, MA USA

[6] Wayne State Univ, Dept Pharm Practice, Antiinfect Res Lab, Detroit, MI USA

[7] Sinai Grace Hosp, Detroit Med Ctr, Dept Pharm, Detroit, MI USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2018年 / 75卷 / 24期

关键词：

area under the curve; minimum inhibitory concentration; pharmacodynamics; pharmacokinetics; S; aureus; vancomycin; RESISTANT STAPHYLOCOCCUS-AUREUS; INHIBITORY CONCENTRATION RATIO; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; CONCENTRATION-TIME CURVE; PHARMACOKINETICS; PHARMACODYNAMICS; EXPOSURE; OUTCOMES; ANTIMICROBIALS;

D O I：

10.2146/ajhp180034

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1986 / 1995

页数：10

共 34 条

[1] Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
不详
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (04) : 388 - 416
[2] [Anonymous], 27 INT C ANT AG CHEM
[3] Evaluation of the Accuracy of a Pharmacokinetic Dosing Program in Predicting Serum Vancomycin Concentrations in Critically Ill Patients
Aubron, Cecile
Corallo, Carmela E.
Nunn, Maya O.
Dooley, Michael J.
Cheng, Allen C.
[J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (10) : 1193 - 1198
[4] Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
Brown, Jack
Brown, Kristen
Forrest, Alan
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (02) : 634 - 638
[5] Carreno JJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02478-16, 10.1128/aac.02478-16]
[6] Association between Vancomycin Day 1 Exposure Profile and Outcomes among Patients with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis
Casapao, Anthony M.
Lodise, Thomas P.
Davis, Susan L.
Claeys, Kimberly C.
Kullar, Ravina
Levine, Donald P.
Rybak, Michael J.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) : 2978 - 2985
[7] Chavada R, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02535-16, 10.1128/aac.02535-16]
[8] VANCOMYCIN PHARMACOKINETICS IN A PATIENT POPULATION - EFFECT OF AGE, GENDER, AND BODY-WEIGHT
DUCHARME, MP
SLAUGHTER, RL
EDWARDS, DJ
[J]. THERAPEUTIC DRUG MONITORING, 1994, 16 (05) : 513 - 518
[9] Finch NA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01293-17, 10.1128/aac.01293-17]
[10] Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools
Fuchs, Aline
Csajka, Chantal
Thoma, Yann
Buclin, Thierry
Widmer, Nicolas
[J]. CLINICAL PHARMACOKINETICS, 2013, 52 (01) : 9 - 22

← 1 2 3 4 →